The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation
- PMID: 35330323
- PMCID: PMC8955716
- DOI: 10.3390/jof8030321
The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation
Abstract
Macrophages are some of the most important immune cells in the organism and are responsible for creating an inflammatory immune response in order to inhibit the passage of microscopic foreign bodies into the blood stream. Sometimes, their activation can be responsible for chronic inflammatory diseases such as asthma, tuberculosis, hepatitis, sinusitis, inflammatory bowel disease, and viral infections. Prolonged inflammation can damage the organs or may lead to death in serious conditions. In the present study, RAW264.7 macrophages were exposed to lipopolysaccharide (LPS; 20 ng/mL) and simultaneously treated with 20 µg/mL of natural-based formulation (NBF), mushroom-cannabidiol extract). Pro-inflammatory cytokines, chemokines, and other inflammatory markers were analyzed. The elevations in the presence of interleukin-6 (IL-6), cycloxygenase-2 (COX-2), C-C motif ligand-5 (CCL5), and nitrite response, following exposure to LPS, were completely inhibited by NBF administration. IL-1β and tumor necrosis factor alpha (TNF-α) release were inhibited by 3.9-fold and 1.5-fold, respectively. No toxic effect of NBF, as assessed by lactate dehydrogenase (LDH) release, was observed. Treatment of the cells with NBF significantly increased the mRNA levels of TLR2, and TLR4, but not NF-κB. Thus, it appears that the NBF possesses anti-inflammatory and immunomodulatory effects which can attenuate the release of pro-inflammatory markers. NBF may be a candidate for the treatment of acute and chronic inflammatory diseases and deserves further investigation.
Keywords: cannabidiol; chemokines; cytokines; inflammation; lipopolysaccharide; macrophages; medicinal mushrooms.
Conflict of interest statement
B.F. and D.M. are employees of Cannabotech Company (Herzliya, Israel).
Figures






Similar articles
-
Phenolic rich Cocos nucifera inflorescence extract ameliorates inflammatory responses in LPS-stimulated RAW264.7 macrophages and toxin-induced murine models.Inflammopharmacology. 2020 Aug;28(4):1073-1089. doi: 10.1007/s10787-019-00620-6. Epub 2019 Jul 26. Inflammopharmacology. 2020. PMID: 31350628
-
Soybean protein-derived peptides inhibit inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPK-JNK and NF-kappa B activation.J Food Biochem. 2020 Aug;44(8):e13289. doi: 10.1111/jfbc.13289. Epub 2020 Jun 14. J Food Biochem. 2020. PMID: 32537742
-
Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages.BMC Complement Altern Med. 2018 Jul 25;18(1):224. doi: 10.1186/s12906-018-2289-3. BMC Complement Altern Med. 2018. PMID: 30045725 Free PMC article.
-
Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-kappaB signaling pathway in murine macrophages.J Ethnopharmacol. 2009 Mar 18;122(2):313-9. doi: 10.1016/j.jep.2008.12.024. Epub 2008 Dec 27. J Ethnopharmacol. 2009. PMID: 19162159
-
Amelioration of an LPS-induced inflammatory response using a methanolic extract of Lagerstroemia ovalifolia to suppress the activation of NF-κB in RAW264.7 macrophages.Int J Mol Med. 2016 Aug;38(2):482-90. doi: 10.3892/ijmm.2016.2646. Epub 2016 Jun 16. Int J Mol Med. 2016. PMID: 27314211
Cited by
-
Effects of combined cannabidiol (CBD) and hops (Humulus lupulus) terpene extract treatment on RAW 264.7 macrophage viability and inflammatory markers.Nat Prod Bioprospect. 2023 Jun 7;13(1):19. doi: 10.1007/s13659-023-00382-3. Nat Prod Bioprospect. 2023. PMID: 37284961 Free PMC article.
-
Polysaccharide of Atractylodes macrocephala Koidz alleviate LPS-induced inflammatory liver injury by reducing pyroptosis of macrophage via regulating LncRNA GAS5/miR-223-3p/NLRP3 axis.Front Pharmacol. 2025 Jul 29;16:1593689. doi: 10.3389/fphar.2025.1593689. eCollection 2025. Front Pharmacol. 2025. PMID: 40799819 Free PMC article.
-
Comparison of the in vitro Anti-Inflammatory Effect of Cannabidiol to Dexamethasone.Clin Cosmet Investig Dermatol. 2022 Sep 16;15:1959-1967. doi: 10.2147/CCID.S378798. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36159203 Free PMC article.
-
Effects and formula optimization of Rosa roxbunghii pomace substrate on the yield and volatile flavor compounds of Lentinulaedodes.Front Plant Sci. 2025 May 26;16:1456290. doi: 10.3389/fpls.2025.1456290. eCollection 2025. Front Plant Sci. 2025. PMID: 40496466 Free PMC article.
-
Development of Novel 1,3-Disubstituted-2-Thiohydantoin Analogues with Potent Anti-Inflammatory Activity; In Vitro and In Silico Assessments.Molecules. 2022 Sep 23;27(19):6271. doi: 10.3390/molecules27196271. Molecules. 2022. PMID: 36234810 Free PMC article.
References
-
- Sarzi-Puttini P., Marotto D., Antivalle M., Salaffi F., Atzeni F., Maconi G., Monteleone G., Rizzardini G., Antinori S., Galli M., et al. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmun. Rev. 2020;19:102574. doi: 10.1016/j.autrev.2020.102574. - DOI - PMC - PubMed
-
- Plassmeyer M., Alpan O., Corley M.J., Premeaux T.A., Lillard K., Coatney P., Vaziri T., Michalsky S., Pang A.P.S., Bukhari Z., et al. Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS-CoV-2 infection and long COVID. Allergy. 2021;77:118–129. doi: 10.1111/all.14907. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials